Yingzi Zhang
8 Papers
Yingzi Zhang is an academic researcher. The author has contributed to research in topics: Biology & Medicine. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
A metal-organic framework/aptamer system as a fluorescent biosensor for determination of aflatoxin B1 in food samples.
TL;DR: A novel fluorescent aptasensor using metal-organic frameworks (UiO-66-NH2) and TAMRA label aptamer as sensing platform for AFB1 detection and provided a reasonable method for other mycotoxin detection by changing the sequence of aptamer.
92
Quantitative haplotype-resolved analysis of mitochondrial DNA heteroplasmy in Human single oocytes, blastoids, and pluripotent stem cells
Chongwei Bi,Lin Wang,Yong Fan,Baolei Yuan,Samhan M Alsolami,Yingzi Zhang,Pu-Yao Zhang,Yanyi Huang,Yang Yu,Juan Carlos Izpisua Belmonte,Mo Li +10 more
TL;DR: In this article , a single-mtDNA analysis of the comprehensive heteroplasmy landscape in single human oocytes and human blastoid was presented, which provided new insights of mtDNA genetics and laid a foundation for understanding mtDNA heterogeneity at early stages of life.
Biochemical Targets and Molecular Mechanism of Matrine against Aging
TL;DR: In this article , the potential targets and molecular mechanism of matrine (MAT) against aging were explored and the top 10 key genes (cyclin D1, cyclin dependent kinase 1, Cyclin A2, androgen receptor, Poly [ADP-ribose] polymerase-1 (PARP1), histone-lysine N-methyltransferase, albumin, mammalian target of rapamycin, histone deacetylase 2, and matrix metalloproteinase 9) were filtered by the molecular complex detection, maximal clique centrality (MMC) algorithm, and degree.
Bioinformatic analysis as a first step to predict the compatibility of hematopoiesis and immune system genes between humans and pigs
TL;DR: This study performs a systematic screening analysis of predicted incompatible genes between humans and pigs, judged by low protein sequence similarities or different predicted protein domain compositions, and provides a good reference for further genetic modification of pigs, which might be beneficial for xenotransplantation.
1
Autologous CD19-directed CAR T cells produced by novel PrimeCARmanufacture platform exhibit safety, efficacy, and long persistence profiles in relapsed/refractory B-lineage acute leukemia (r/r B-ALL).
Shiqi Li,Zhi Yang,Zucong Chen,Yu Li,Lin Liu,Zhong Yuan,Yingzi Zhang,Le Luo,Lihua Fang,Yingnian Chen,Qianzhen Zhang,Junjie Shen,Yunyan Li,Linling Wang,Meiling Wang,Wei Zhu,Sanbin Wang,Cheng Qian +17 more
TL;DR: Treatment of r/r B-ALL at very low dose resulted in excellent safety profile, while exhibited a promising efficacy, which make this PrimeCAR platform potential for outpatient administration in the future.